Barclays analyst Tom O’Malley raised the firm’s price target on Astera Labs (ALAB) to $87 from $70 and keeps an Overweight rating on the shares. Aries drove another quarter of upside, bridging the gap to a strong year ahead led by Scorpio and Gen 6, the analyst tells investors in a research note.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB: